Tackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
Tackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Clinical trials are evolving to meet the needs of patients and researchers alike. However, is the industry prepared to tackle emerging challenges in tech-enabled trials?
In today's episode, our guest, Beth Hoffman, CEO of Origami Therapeutics, discusses these issues and gives insights on how they can be addressed.
Listen to our latest podcast now for more info!
Are you a sponsor looking for technology solutions to democratize your trials? Visit our website at https://www.castoredc.com/ for more information
Pas encore de commentaire